LYSODREN

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug LYSODREN contains one active pharmaceutical ingredient (API):

1 Mitotane
UNII 78E4J5IB5J - MITOTANE

Mitotane is an adrenal cytotoxic active substance, although it can apparently also cause adrenal inhibition without cellular destruction. Available data suggest that mitotane modifies the peripheral metabolism of steroids and that it also directly suppresses the adrenal cortex. The administration of mitotane alters the extra-adrenal metabolism of cortisol in humans, leading to a reduction in measurable 17-hydroxy corticosteroids, even though plasma levels of corticosteroids do not fall.

Read about Mitotane

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LYSODREN Tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XX23 Mitotane L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00463221
Country: EE Ravimiamet Identifier(s): 1208461, 1735972, 1849765
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 04273001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 020282
Country: FR Base de données publique des médicaments Identifier(s): 66435544
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 94674
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 20099
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029634
Country: NL Z-Index G-Standaard, PRK Identifier(s): 37818
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100111570
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66770001
Country: US FDA, National Drug Code Identifier(s): 0015-3080, 76336-080

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.